Howard Leonhardt is the brand behind Second Heart Assist, a company specializing in the development of advanced solutions for combatting heart failure. Their innovative technology, showcased in MedTech Outlook Magazine, includes the Gen I catheter-based pump and the Gen II wireless powered chronic implant, both of which aim to reverse cardio-renal dysfunction. With a focus on cutting-edge medical devices, Howard Leonhardt's brand delivers an improved solution for patients in need.

The brand has achieved significant milestones, such as securing 20 new patent claims from the US Patent and Trademark Office for their circulatory assist device technology platform. They have also filed a patent for an electro-activated shape-changing impeller for circulatory assist devices. Additionally, Second Heart Assist has successfully completed long-duration pre-clinical studies and is set to present clinical data at the American Society for Artificial Internal Organs 66th Annual Conference.

Howard Leonhardt's dedication to innovation and commitment to improving patient outcomes make them a leader in the field of heart failure treatment